Get smarter, sleep better, and achieve success by checking out the GRSM ADvice Vlog!
A seismic event has hit GLP-1’s, drug compounding, and telemedicine!The FDA has removed Semaglutide and Tirzepatide from the FDA shortage list!
And drug company patent owners are suing to shut down compounding pharmacies!
What does this mean for telemedicine marketers selling compounded versions?
What strategies are telemedicine marketers exploring to save the compounded weight loss drug market?
What are the strengths and weaknesses of these strategies?
Watch to learn from Jason Kalkirtz!